Table 2.
Correlation of miR-219–5p Expression With Clinicopathologic Features in PTC
| Clinicopathologic Parameters | Case No. | miR-219–5p Expression | P Value |
|---|---|---|---|
| Total cases | 30 | ||
| Age | .4979 | ||
| ≤60 y | 16 | 1.139 ± 0.671 | |
| >60 y | 14 | 1.325 ± 0.815 | |
| Sex | .0102 | ||
| Male | 12 | 1.669 ± 0.531 | |
| Female | 18 | 1.057 ± 0.634 | |
| Tumor | .0041 | ||
| ≤5 cm | 14 | 1.637 ± 0.620 | |
| >5 cm | 16 | 0.980 ± 0.533 | |
| Lymph node metastasis | .0150 | ||
| Negative | 13 | 1.783 ± 0.917 | |
| Positive | 17 | 1.039 ± 0.658 | |
| Extrathyroid extension | |||
| None | 13 | 1.783 ± 0.917 | |
| Microscopic | 11 | 1.125 ± 0.790 | .0753 |
| Macroscopic | 6 | 0.881 ± 0.304 | .0479 |
| PTC subtype | |||
| Typical PTC | 12 | ||
| Papillary microcarcinoma | 4 | ||
| Tall cell variant | 3 | ||
| Intracystic papillary carcinoma | 2 | ||
| Diffuse sclerosing variant | 2 | ||
| Oncocytic variant | 2 | ||
| Follicular variant | 2 | ||
| Solid variant | 2 | ||
| Insular variants | 1 |
Clinicopathologic information of patients with PTC and miR-219–5p expression in different clinicopathologic features. All RQ values are expressed as means ± SD.